Evidence map›Paper›PMID 39500942›Full record

ArticleScientific reports2024

Regulation of neutrophil associated RNASET2 expression in rheumatoid arthritis.

Mauro Passari, Sara Scutera, Tiziana Schioppa, Laura Tiberio, Silvia Piantoni, Nicola Tamassia, Mattia Bugatti, William Vermi, Fabrizio Angeli, Alessia Caproli and 12 more

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Mauro PassariDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Sara ScuteraDepartment of Public Health and Pediatrics, University of Turin, Turin, Italy.
Tiziana SchioppaDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Laura TiberioDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Silvia PiantoniDepartment of Clinical and Experimental Sciences, Unit of Rheumatology and Clinical Immunology - ASST, University of Brescia, Spedali Civili of Brescia, Brescia, Italy.
Nicola TamassiaDepartment of Medicine, Section of General Pathology, University of Verona, Verona, Italy.
Mattia BugattiDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
William VermiDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Fabrizio AngeliDepartment of Clinical and Experimental Sciences, Unit of Rheumatology and Clinical Immunology - ASST, University of Brescia, Spedali Civili of Brescia, Brescia, Italy.
Alessia CaproliDepartment of Clinical and Experimental Sciences, Unit of Rheumatology and Clinical Immunology - ASST, University of Brescia, Spedali Civili of Brescia, Brescia, Italy.
Valentina SalviDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Francesca SozioDepartment of Molecular Medicine, Laboratory Affiliated to Istituto Pasteur Italia- Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy.
Angela GismondiDepartment of Molecular Medicine, Laboratory Affiliated to Istituto Pasteur Italia- Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy.
Helena StabileDepartment of Molecular Medicine, Laboratory Affiliated to Istituto Pasteur Italia- Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy.
Franco FranceschiniDepartment of Clinical and Experimental Sciences, Unit of Rheumatology and Clinical Immunology - ASST, University of Brescia, Spedali Civili of Brescia, Brescia, Italy.
Daniela BosisioDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy.
Francesco AcquatiHuman Genetics Laboratory, Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
Sonja VermerenCentre for Inflammation Research, Institute for Regeneration and Repair, The University of Edinburgh, Edinburgh, UK.
Silvano SozzaniDepartment of Molecular Medicine, Laboratory Affiliated to Istituto Pasteur Italia- Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy.
Laura AndreoliDepartment of Clinical and Experimental Sciences, Unit of Rheumatology and Clinical Immunology - ASST, University of Brescia, Spedali Civili of Brescia, Brescia, Italy.
Annalisa Del PreteDepartment of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, Brescia, 25123, Italy. annalisa.delprete@unibs.it.ORCID http://orcid.org/0000-0002-3738-412X
Tiziana MussoDepartment of Public Health and Pediatrics, University of Turin, Turin, Italy.

Funding

Ministero dell'Università e della Ricerca PNRR-European Union PE08 Age-ItMinistero dell'Università e della Ricerca PRIN2017 No. NTK4HY
6 · The paper itself

Abstract

Neutrophils (PMNs) are key players of innate immune responses through the release of cytoplasmic granule content and the formation of neutrophil extracellular traps (NETs). RNASET2 is an acidic ribonuclease, recently proposed as an alarmin signal associated with inflammatory responses. Here we show that, along the neutrophil maturation cascade, RNASET2 is expressed in segmented and mature PMNs. In human PMNs, RNASET2 colocalized with primary and tertiary granules and was found to be associated with NETs following PMA or Nigericin stimulation. Similarly, activation of PMNs by soluble immune complexes, a hallmark of several autoimmune diseases, also induced RNASET2-associated NETs. Genome-wide association studies recently identified RNASET2 among a cluster of genes associated with increased susceptibility to develop autoimmune diseases, including rheumatoid arthritis (RA). RNASET2 was found expressed by PMNs and macrophages infiltrating inflamed joints in a murine model of RA (K/BxN Serum-Transfer-Induced Arthritis, STIA), by immunostaining. Similar results were found in synovial biopsies of RA patients with active disease. In addition, we demonstrate that RNASET2 circulating levels correlated with the onset and the severity of disease in two mouse models of inflammatory arthritis, STIA and CIA (Collagen-Induced Arthritis) and in serum of RA patients. These results show that PMNs are an important source of RNASET2 and that its circulating levels are associated with RA development suggesting a role for RNASET2 in the pathogenesis of immune-mediated diseases.

Indexed as

Arthritis, RheumatoidExtracellular TrapsNeutrophilsAnimalsArthritis, ExperimentalDisease Models, AnimalFemaleGene Expression RegulationHumansMacrophagesMaleMiceRibonucleasesTumor Suppressor ProteinsRibonucleasesRNASET2 protein, humanTumor Suppressor Proteins

Identifiers

PMID39500942
PMCPMC11538310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.